title: [Calcium antagonists and blood filterability].
authors.forename: C
authors.initials: C
authors.lastname: Muggia
authors.forename: M G
authors.initials: MG
authors.lastname: Ranieri
authors.forename: L
authors.initials: L
authors.lastname: Bobba
authors.forename: F
authors.initials: F
authors.lastname: Testa
authors.forename: A
authors.initials: A
authors.lastname: Martignoni
authors.forename: G
authors.initials: G
authors.lastname: Perani
authors.forename: G
authors.initials: G
authors.lastname: Finardi
mesh_terms: D000328:Adult; D000368:Aged; D002121:Calcium Channel Blockers / Q000494:pharmacology*; D002986:Clinical Trials as Topic; D004311:Double-Blind Method; D004907:Erythrocyte Deformability / Q000187:drug effects*; D005260:Female; D006801:Humans; D006973:Hypertension / Q000097:blood / Q000188:drug therapy; D008297:Male; D008875:Middle Aged; D009543:Nifedipine / Q000494:pharmacology / Q000627:therapeutic use; D011437:Propylamines / Q000494:pharmacology / Q000627:therapeutic use; D011897:Random Allocation; D013976:Tiapamil Hydrochloride
chemical_list: D002121:Calcium Channel Blockers; D011437:Propylamines; D009543:Nifedipine; D013976:Tiapamil Hydrochloride
vernacular_title: Calcioantagonisti e filtrabilità ematica.